As Americans report ever-growing difficulty affording their prescription drugs, President Donald Trump has come under increasing pressure to act. To date, the Trump administration has attempted to advance a number of policy initiatives by means of executive action, but it has not yet adopted a program that would meaningfully assist patients. Most recently, the administration proposed a rule that, if finalized, would allow states to develop programs to import lower-priced prescription drugs from Canada, with the intent of reducing spending on drugs by U.S. patients and states and increasing access for patients.
Sachs, Rachel E. "Importing Prescription Drugs from Canada — Legal and Practical Problems with the Trump Administration's Proposal." Nicholas Bagley, co-author. New Eng. J. Med. 382, no. 19 (2020): 1777-9.